The Telethon Kids Institute is looking for healthy babies (born from 35 weeks of pregnancy onwards) to take part in an important study evaluating a new medication that may help prevent Respiratory Syncytial Virus (RSV) disease.
RSV is one of the most common reasons babies and young children are admitted to hospital. RSV can lead to severe complications such as bronchiolitis and pneumonia, but there are currently no medicines available to prevent RSV in healthy infants or medications available to treat it.
If your baby is less than 12 months of age they may be eligible to participate. If you, your friends or relatives are interested in finding out more about this study, please contact the study team at Telethon Kids Institute on 0400 450 240 or email email@example.com.